llumina Acquires Epicentre Biotechnologies, Leading Provider of Nucleic Acid Sample Preparation Reagents and Specialty Enzymes

Combination Enhances Illumina's Sample Preparation and Enzyme Portfolio SAN DIEGO - Illumina, Inc. (NASDAQ:ILMN) today announced that it has acquired Epicentre Biotechnologies, a leading provider of nucleic acid sample preparation reagents and specialty enzymes used in sequencing and microarray applications. A key component of the acquisition is direct access to Epicentre's proprietary Nextera(TM) technology for [...]

Life Technologies Announces $500 Million Share Repurchase Program

CARLSBAD, Calif. - Life Technologies Corporation (NASDAQ: LIFE) today announced a share repurchase program for up to $500 million. This program authorizes management, at its discretion, to repurchase shares on the open market or in privately negotiated transactions, subject to market conditions and other factors. “The company remains committed to our long-term growth plan and [...]

Illumina Announces MiSeq(TM) Personal Sequencing System

Delivers Next-Generation Sequencing to Individual Researchers SAN DIEGO - Illumina, Inc. (NASDAQ:ILMN) today announced MiSeq(TM), a low-cost personal sequencing system that provides individual researchers a platform with rapid turnaround time, unmatched accuracy, and radically improved ease of use. Leveraging the company's TruSeq(TM) sequencing chemistry, the system's revolutionary workflow offers the flexibility to go from purified [...]

Rockland Immunochemicals Awarded Phase I SBIR Funding to Develop Generic Antibodies “Biosimilars” for the Treatment of Cancer

GILBERTSVILLE, Pa.--Rockland Immunochemicals Inc., (www.rockland-inc.com) a biotechnology company focusing on antibodies and antibody based tools for basic research, diagnostic assay development and preclinical studies, today announced that it has received a Phase I Small Business Innovation Research (SBIR) grant from the National Institutes of Health to develop Generic Antibodies “Biosimilars” for the Treatment of Cancer. [...]

Photon Control Proudly Releases New High Sensitivity UV to NIR Spectrometer to Successful Line Up

Burnaby, B.C. - Photon Control Inc. ("Photon Control") (TSX-V: PHO), a leading developer of innovative measurement technologies, is pleased to announce the release of the New SPM-002-XT64 to Photon Control’s successful line up of Spectrometers. The SPM-002-XT64 is now the most versatile spectrometer optical bench in the Photon Control product line. It is equipped with [...]

Beckman Coulter Releases 2011 Cellular Analysis eCatalog on www.coulterflow.com

Dynamic Platform Simplifies Lab Management and Product Selection ORANGE COUNTY, CALIF. - Beckman Coulter, Inc. announces the release of its 2011 Cellular Analysis eCatalog, which combines with www.coulterflow.com to provide a comprehensive, adaptable and eco-friendly resource that simplifies the reagent and instrument selection process and improves day-to-day management of a lab’s experiments and needs. This [...]

EyeSense Attracts QIAGEN as Strategic Investor

BASEL, Switzerland - EyeSense AG, a leading developer of novel ophthalmic self-diagnostic systems for glucose monitoring of diabetes patients, today announced that it has entered into a strategic partnership with QIAGEN (NASDAQ: QGEN; Frankfurt, Prime Standard: QIA). Capitalizing on QIAGEN's ESE fluorescence-based optical technology and on Eyesense's glucose sensing technology, the partners intend to develop [...]

Hach Announces HQd Benchtop Laboratory Meter and Ammonia Ion Selective Electrode Probe

Hach further expands its comprehensive line of HQd digital meters and plug-and-play IntelliCAL™ probes Loveland, Colo. - Hach Company (www.hach.com) announces the expansion of its electrochemistry offering with the new HQd Benchtop meter and IntelliCAL™ ammonia ion selective electrode (ISE) probe. Designed to accurately test water quality, the Hach HQd benchtop meter and ammonia probe [...]

Agilent Technologies Secures Patent for Porous Shell LC Particle Manufacturing Technology

SANTA CLARA, Calif. - Agilent Technologies Inc. (NYSE: A) today announced that it was awarded a U.S. patent for the process used to apply the superficially porous shell to particles in Agilent Poroshell 120 high-performance liquid chromatography (HPLC) columns. The patent was issued for the unique coacervation process used to manufacture the Poroshell 120 silica. [...]

New Genedata Screener Presented at CHI High Content Analysis Conference

Screener 9 delivers an enterprise hub for HCS data, linking multiple instruments and image management systems to create cost efficiencies and improved productivity San Francisco, Calif. - Genedata, a leading provider of advanced software solutions for drug discovery and life science research, today announced a new version of Genedata Screener®, a comprehensive software system for [...]

Access IBO on Knowledge Center